Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.46 |
| ▸ | PTPRC | P08575 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69894 | 1.00 | MEN1 (0.47) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL30701140 | 0.84 | MAOA (0.61) | MEN1KMT2ACYP2C19MAOAPTPRC | |
| SCHEMBL577689 | 0.84 | TDP1 (0.42) | MEN1KMT2ACYP3A4KDM4ETP53 | |
| SCHEMBL730635 | 0.83 | HRH1 (0.58) | MEN1KMT2AKDM4EPTPRCCTSL | |
| SCHEMBL31317931 | 0.83 | HRH1 (0.58) | MEN1KMT2AKDM4EPTPRCCTSL | |
| SCHEMBL17427081 | 0.83 | CYP2C19 (0.41) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16547365 | 0.81 | CYP1A2 (0.42) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL9267882 | 0.81 | KMT2A (0.43) | MEN1KMT2ACYP2C19METAP2PTPRC | |
| SCHEMBL9263914 | 0.80 | CYP2A6 (0.41) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL9261195 | 0.80 | CYP2A6 (0.41) | MEN1KMT2AMAOATDP2NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120518639-A | Indeno [1,2-b ] pyridine-5-ketone condensed oxa-carbole compound and preparation method thereof | 湖南科技大学 | 2025-08-22 | — | — | CN | disclosed |
| CN-120518639-A | Indeno [1,2-b ] pyridine-5-ketone condensed oxa-carbole compound and preparation method thereof | 湖南科技大学 | 2025-08-22 | — | — | CN | disclosed |
| CN-119409635-A | Fluoro methyl substituted indeno [1,2-b ] pyridine compound with anticancer activity and synthesis method thereof | 河南师范大学 | 2025-02-11 | — | — | CN | disclosed |
| US-11655264-B2 | Metallocene compounds, and preparation and use thereof for synthesis of poly-alpha-olefins as lubricating base oil | APALENE TECHNOLOGY CO., LTD. (HANGZHOU) (CN) | 2023-05-23 | — | — | US | disclosed |
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | MEN1 3119/4885KMT2A 4132/4885CYP3A4 264/4885 |
| US-11655264-B2 | Metallocene compounds, and preparation and use thereof for synthesis of poly-alpha-olefins as lubricating base oil | POLM, POLA1, POLD1 | MEN1 876/4885KMT2A 3067/4885CYP3A4 844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.